EUVIMEDEUVIMED entdecken
Crossref

Impact of dienogest therapy on CA125 levels, hormonal profile, and systemic inflammatory indices in endometriosis

Funda Bulut Arıkan, Nevin Sağsöz

Journal of Controversies in Obstetrics & Gynecology and Pediatrics · 30.04.2026 · 4 (2) · 25-30

DOI: 10.51271/jcogp-0069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controversies in Obstetrics & Gynecology and Pediatrics, online erschienen am 30.04.2026. Verfasst von Funda Bulut Arıkan und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The present study aims to evaluate the impact of dienogest therapy on CA125 levels, hormonal profile, and systemic inflammatory indices in patients with endometriosis, a chronic inflammatory disorder in which inflammation constitutes a fundamental component of the pathophysiology.

Methods

This retrospective, pre–post analytical study included 150 female with endometriosis who received dienogest. Demographic and laboratory data were obtained from electronic medical records. Systemic inflammatory indices including neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), neutrophil-to-monocyte ratio (NMR), plateletto-lymphocyte ratio (PLR), mean platelet volume (MPV), MPV-to-lymphocyte ratio (MPVLR), cancer antigen 125 (CA-125), Systemic Immune-inflammation Index (SII), Systemic Inflammation Response Index (SIRI), and pan-immune-inflammation value (PIV) were evaluated before and after treatment. Statistical analyses were performed using appropriate parametric and nonparametric tests, and correlation analyses were conducted.

Results

Following dienogest therapy, statistically significant reductions were observed in CA125 levels (p=0.010) and PLR (p=0.028), along with decreases in leukocyte, and PCT levels. FSH levels showed a significant increase (p=0.001), whereas LH, estradiol, progesterone, TSH, FT3, and FT4 levels remained unchanged (p>0.05 for all). Significant increases were also noted in hemoglobin, hematocrit, MCV, and MCH values after treatment (p

Zitieren

APA

Arıkan, F. B., & Sağsöz, N. (2026). Impact of dienogest therapy on CA125 levels, hormonal profile, and systemic inflammatory indices in endometriosis. Journal of Controversies in Obstetrics & Gynecology and Pediatrics, 4(2), 25-30. https://doi.org/10.51271/jcogp-0069

Vancouver

Arıkan FB, Sağsöz N. Impact of dienogest therapy on CA125 levels, hormonal profile, and systemic inflammatory indices in endometriosis. Journal of Controversies in Obstetrics & Gynecology and Pediatrics. 2026;4(2):25-30. doi:10.51271/jcogp-0069

BibTeX
@article{Arkan2026,
  author = {Arıkan, Funda Bulut and Sağsöz, Nevin},
  title = {Impact of dienogest therapy on CA125 levels, hormonal profile, and systemic inflammatory indices in endometriosis},
  journal = {Journal of Controversies in Obstetrics & Gynecology and Pediatrics},
  year = {2026},
  volume = {4},
  number = {2},
  pages = {25--30},
  doi = {10.51271/jcogp-0069}
}
Kostenlos starten →